\-\ Texto\\:\\ \ \(0\)\
\-\ rash\\ on\\ head\\ consistent\\ with\\ shingles\\.\ \(0\)\
\-\ patient\\ treated\\ with\\ acyclovir\\.\\ \\ aphasia\\ rapidly\\ resolved\\.\\ \\ \ \(0\)\
\-\ no\\ permanent\\ neurological\\ deficit\\.\ \(0\)\
\-\ \\â\\€\\¢\\ lesion\\ in\\ left\\ temporal\\ lobe\\ which\\ demonstrates\\ high\\ signal\\ intensity\\ on\\ t2\\ and\\ flair\\ sequences\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ dwi\\ images\\ are\\ positive\\.\\ no\\ mass\\ effect\\.\\ \\ \ \(0\)\
\-\ \\â\\€\\¢\\ enhancement\\ at\\ base\\ of\\ temporal\\ lobe\\ in\\ the\\ region\\ of\\ the\\ foramen\\ ovale\\.\ \(0\)\
\-\ varicella\\ zoster\\ with\\ temporal\\ lobe\\ involvement\ \(0\)\
\-\ \\â\\€\\¢\\ stroke\ \(0\)\
\-\ \\â\\€\\¢\\ cerebral\\ contusion\ \(0\)\
\-\ \\â\\€\\¢\\ encephalitis\ \(1\)\
\-\ 62\\ year\\ old\\ man\\ presents\\ to\\ er\\ with\\ aphasia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ aphasia\\:\\ 0\\.12515188882514772\ \(0\)\
\-\ temporal\\:\\ 0\\.11936828642840012\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.10932658266948055\ \(0\)\
\-\ shingles\\:\\ 0\\.08379163385502789\ \(0\)\
\-\ lobe\\:\\ 0\\.08020902376477444\ \(0\)\
\-\ zoster\\:\\ 0\\.07832647537542631\ \(0\)\
\-\ varicella\\:\\ 0\\.07695690519337532\ \(0\)\
\-\ acyclovir\\:\\ 0\\.07462352501358288\ \(0\)\
\-\ ovale\\:\\ 0\\.07361176481602905\ \(0\)\
\-\ permanent\\:\\ 0\\.06375946411385225\ \(0\)\
\-\ rash\\:\\ 0\\.06051861059677062\ \(0\)\
\-\ encephalitis\\:\\ 0\\.055493804141069164\ \(0\)\
\-\ rapidly\\:\\ 0\\.055092802093729985\ \(0\)\
\-\ contusion\\:\\ 0\\.05470516929992078\ \(0\)\
\-\ 62\\:\\ 0\\.05433004299505774\ \(0\)\
\-\ dwi\\:\\ 0\\.05277735238314468\ \(0\)\
\-\ stroke\\:\\ 0\\.051846623224150075\ \(0\)\
\-\ deficit\\:\\ 0\\.05126510670584006\ \(0\)\
\-\ resolved\\:\\ 0\\.04817080918028595\ \(0\)\
\-\ foramen\\:\\ 0\\.04743395320432561\ \(0\)\
\-\ flair\\:\\ 0\\.0455544026048324\ \(0\)\
\-\ neurological\\:\\ 0\\.0429944722273226\ \(0\)\
\-\ sequences\\:\\ 0\\.04149412036983735\ \(0\)\
\-\ base\\:\\ 0\\.03892393352129496\ \(0\)\
\-\ er\\:\\ 0\\.03811842042962746\ \(0\)\
\-\ involvement\\:\\ 0\\.0364178913561374\ \(0\)\
\-\ intensity\\:\\ 0\\.035914775306736056\ \(0\)\
\-\ effect\\:\\ 0\\.03518090991940982\ \(0\)\
\-\ cerebral\\:\\ 0\\.03442379653214036\ \(0\)\
\-\ positive\\:\\ 0\\.0322428557009781\ \(0\)\
\-\ treated\\:\\ 0\\.029742451582370457\ \(0\)\
\-\ head\\:\\ 0\\.02818141058806856\ \(0\)\
\-\ t2\\:\\ 0\\.02812312521802735\ \(0\)\
\-\ region\\:\\ 0\\.028065130549294333\ \(0\)\
\-\ high\\:\\ 0\\.027192396059032738\ \(0\)\
\-\ enhancement\\:\\ 0\\.02663359030375623\ \(0\)\
\-\ signal\\:\\ 0\\.026198538724102077\ \(0\)\
\-\ consistent\\:\\ 0\\.02436393335850236\ \(0\)\
\-\ man\\:\\ 0\\.023499207477790687\ \(0\)\
\-\ demonstrates\\:\\ 0\\.021704897693641697\ \(0\)\
\-\ presents\\:\\ 0\\.0202981894826503\ \(0\)\
\-\ lesion\\:\\ 0\\.02023901425581924\ \(0\)\
\-\ no\\:\\ 0\\.02001032908613493\ \(0\)\
\-\ images\\:\\ 0\\.01906120804592272\ \(0\)\
\-\ which\\:\\ 0\\.018548192874913355\ \(0\)\
\-\ on\\:\\ 0\\.016834674706172746\ \(0\)\
\-\ mass\\:\\ 0\\.013819314034274006\ \(0\)\
\-\ are\\:\\ 0\\.013545045029413973\ \(0\)\
\-\ at\\:\\ 0\\.01346236224222829\ \(0\)\
\-\ left\\:\\ 0\\.011117503131080404\ \(0\)\
\-\ year\\:\\ 0\\.011117503131080404\ \(0\)\
\-\ old\\:\\ 0\\.010173658103049472\ \(0\)\
\-\ patient\\:\\ 0\\.00996037128972544\ \(0\)\
\-\ in\\:\\ 0\\.009799935584657091\ \(0\)\
\-\ with\\:\\ 0\\.005442054701855337\ \(0\)\
\-\ to\\:\\ 0\\.004965908237709142\ \(0\)\
\-\ \\.\\:\\ 0\\.0037150677311176337\ \(0\)\
\-\ the\\:\\ 0\\.0032150996442703674\ \(0\)\
\-\ of\\:\\ 0\\.002709390716232289\ \(0\)\
\-\ and\\:\\ 0\\.0020931279736304473\ \(0\)\
